当前位置:首页 - 行情中心 - 新光药业(300519) - 财务分析 - 现金流量表

新光药业

(300519)

  

流通市值:19.39亿  总市值:27.18亿
流通股本:1.14亿   总股本:1.60亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金204,216,742.19141,551,545.1599,159,239.63261,479,281.1
  收到其他与经营活动有关的现金12,460,655.6611,185,643.078,640,620.6220,761,930.82
  经营活动现金流入小计216,677,397.85152,737,188.22107,799,860.25282,241,211.92
  购买商品、接受劳务支付的现金96,969,962.2567,224,518.5534,027,048.76141,119,970.99
  支付给职工以及为职工支付的现金26,634,509.2119,280,341.9711,686,571.9233,454,749.09
  支付的各项税费25,197,618.4918,992,938.0313,434,788.323,399,503.81
  支付其他与经营活动有关的现金17,287,251.8910,412,245.686,826,186.0430,832,935.77
  经营活动现金流出小计166,089,341.84115,910,044.2365,974,595.02228,807,159.66
  经营活动产生的现金流量净额50,588,056.0136,827,143.9941,825,265.2353,434,052.26
二、投资活动产生的现金流量:
  取得投资收益收到的现金3,080,095.342,293,253.87860,420.445,136,438.95
  处置固定资产、无形资产和其他长期资产收回的现金净额27,00027,00021,000100,000
  收到的其他与投资活动有关的现金345,000,000235,000,00095,000,000580,000,000
  投资活动现金流入小计348,107,095.34237,320,253.8795,881,420.44585,236,438.95
  购建固定资产、无形资产和其他长期资产支付的现金3,480,119.273,241,927.27839,886.255,200,158.65
  支付其他与投资活动有关的现金560,000,000420,000,00080,000,000610,000,000
  投资活动现金流出小计563,480,119.27423,241,927.2780,839,886.25615,200,158.65
  投资活动产生的现金流量净额-215,373,023.93-185,921,673.415,041,534.19-29,963,719.7
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金1,000,0001,000,000-1,000,000
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计1,000,0001,000,000-1,000,000
  分配股利、利润或偿付利息支付的现金48,000,00048,000,000-64,000,000
  支付其他与筹资活动有关的现金1,000,0001,000,000-1,000,000
  筹资活动现金流出平衡项目00-0
  筹资活动现金流出小计49,000,00049,000,000-65,000,000
  筹资活动产生的现金流量净额平衡项目00-0
  筹资活动产生的现金流量净额-48,000,000-48,000,000--64,000,000
五、现金及现金等价物净增加额-212,784,967.92-197,094,529.4156,866,799.42-40,529,667.44
  加:期初现金及现金等价物余额503,416,125.46503,416,125.46503,416,125.46543,945,792.9
  期末现金及现金等价物余额290,631,157.54306,321,596.05560,282,924.88503,416,125.46
补充资料:
  净利润-31,907,696.41-50,389,992.99
  资产减值准备-177,676.58-390,462.36
  固定资产和投资性房地产折旧-7,459,233.05-14,642,032
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-7,459,233.05-14,642,032
  无形资产摊销-145,311.58-290,623.16
  处置固定资产、无形资产和其他长期资产的损失-3,722.27-67,847.01
  固定资产报废损失-16,406.3-6,700
  投资损失--2,185,287.2--4,869,269.7
  递延所得税-88,019.7--50,093.19
  其中:递延所得税资产减少-88,019.7--50,093.19
  存货的减少-7,563,721.93-1,690,745.24
  经营性应收项目的减少-4,345,749.55--2,687,626.61
  经营性应付项目的增加--12,647,916.64--6,547,057.09
  现金的期末余额-306,321,596.05-503,416,125.46
  减:现金的期初余额-503,416,125.46-543,945,792.9
  现金及现金等价物的净增加额--197,094,529.41--40,529,667.44
公告日期2025-10-282025-08-262025-04-282025-04-21
审计意见(境内)标准无保留意见
TOP↑